Formulation Development
Dosage-form design, excipient selection, strength calculations, feasibility work, and reproducible preparation methods tailored to the study protocol.
Pharmacy Research Consulting is a collaborative team of pharmacists, pharmaceutical scientists, and chemists who help investigators translate promising ideas into workable studies.
We provide practical, hands-on support from early formulation through analytical testing, stability, blinded product preparation, packaging, and study-site distribution.

Curious scientists. Practical problem-solvers.
At Pharmacy Research Consulting, we love helping promising research move from the “Wouldn’t it be great if…” stage to a functioning investigational study.
Our team combines pharmaceutical formulation, compounding, analytical chemistry, and clinical-research experience to solve the practical problems that can otherwise keep a project grounded. Whether the need involves developing a dosage form, preparing active and placebo products, establishing a reproducible process, coordinating analytical testing, or supplying investigational products to study sites, we work alongside researchers to find a realistic path forward.
Many worthwhile studies begin with limited funding, small research teams, or a formulation challenge that does not fit neatly into a conventional manufacturing model. That is where we are at our best.
We provide focused, practical support without requiring investigators to build an entire pharmaceutical-development department or immediately assume the expense of a large contract manufacturer. Our goal is to provide the scientific, formulation, production, and analytical expertise needed to move a promising project forward—while respecting its budget, timeline, and scientific purpose.
We enjoy challenging projects, unusual dosage forms, and research questions that require thoughtful problem-solving. If your study has scientific potential but needs an experienced pharmaceutical team to help make it possible, we would be glad to explore it with you.
Bring us the “what if…”Focused pharmaceutical capabilities that help researchers move through the practical work between concept and implementation.
Dosage-form design, excipient selection, strength calculations, feasibility work, and reproducible preparation methods tailored to the study protocol.
Protocol-specific active formulations and noncommercial strengths prepared with the practical needs of investigators, sites, and participants in mind.
Coordination and scientific support for potency, purity, dissolution, and other analytical testing needed to characterize study products.
Stability-protocol development, sample preparation, testing coordination, data review, and practical support for study-product dating decisions.
Reproducible preparation of active, matched placebo, and control products with attention to blinding and protocol-specific requirements.
Study-specific packaging, labeling, dispensing, kit preparation, shipment, resupply, and coordination with participating research sites.
Our team has supported investigator-initiated and NIH-funded research across pulmonary medicine, metabolic disease, cardiovascular health, pediatric research, addiction treatment, and individualized drug delivery.
Evaluates whether soy-isoflavone supplementation can reduce wheezing and influence asthma development in infants at increased risk.
View our contribution +Developed the NovaSoy-based investigational formulation using calculated genistein equivalents; compounded active and matched placebo products in protocol-specific strengths; conducted formulation and stability studies; and managed labeling, packaging, and dispensing.
Investigates L-citrulline as a metabolic approach to improving late-onset asthma in individuals with obesity.
View our contribution +Developed and compounded the active formulation and matched placebo; performed stability studies; supported study blinding and randomization; and managed protocol-specific packaging, labeling, dispensing, and investigational-product supply.
A Phase 2 investigation of L-citrulline supplementation in deployment-related asthma.
View our contribution +Developed the compounded active formulation and matched placebo; conducted stability studies; supported blinded study-product preparation; and managed protocol-specific packaging, labeling, dispensing, and resupply.
Evaluates the metabolic effects of SGLT2 inhibition in adolescents with obesity-associated fatty liver disease.
View our contribution +Compounded investigational and control formulations; prepared and supplied specialized isotope products; performed formulation and stability studies; and managed blinded packaging, labeling, and dispensing.
Investigates whether L-carnosine supplementation can improve skeletal-muscle performance and functional capacity in patients with heart failure.
View our contribution +Developed and compounded pharmaceutical-grade L-carnosine capsules and matched placebo; conducted formulation and stability studies; and managed blinded bottling, labeling, packaging, and dispensing.
Examines whether L-carnosine supplementation can improve circulation, walking ability, and lower-extremity function in patients with peripheral arterial disease.
View our contribution +Developed and compounded the investigational formulation and control products; conducted formulation and stability studies; and provided protocol-specific packaging, labeling, and dispensing.
Explores individualized opioid-tapering regimens and novel dosage forms designed to support gradual, patient-specific dose reduction.
View our contribution +Provides pharmaceutical formulation, compounded active and control products, stability studies, investigational-product dispensing, and development support for highly individualized dosage forms, including applications involving three-dimensional pharmaceutical printing.
An investigational molecule being studied as a potential treatment for alcohol-use disorder and craving.
View our contribution +Developed and compounded the protocol-specific investigational formulation and control products; performed formulation and stability studies; and managed investigational-product packaging, labeling, and dispensing.
Three independent professionals bringing complementary experience in formulation, compounding, pharmacology, medicinal chemistry, bioanalysis, and clinical research.

Pharmaceutical Formulation & Pharmacology Consultant
Peter J. Rice is a pharmacist and pharmacologist with extensive experience in pharmaceutical formulation, pharmacokinetics, drug-receptor interactions, and translational research. He has authored more than 60 scientific publications and contributed to numerous preclinical, clinical, and NIH-funded studies. Dr. Rice's work encompasses formulation development, stability testing, transdermal drug absorption, and investigational dosage-form development. A Fellow of the American Pharmacists Association and Board-Certified Pharmacotherapy Specialist, he also brings decades of academic leadership, teaching, mentorship, and research experience to Pharmacy Research Consulting.

Drug Formulation & Compounding Consultant
Adam R. McHenry is a compounding pharmacist, formulation specialist, and founder and president of Sky Ridge Compounding Pharmacy. With approximately two decades of hands-on compounding experience, he specializes in developing individualized medications and investigational dosage forms that are not commercially available. Dr. McHenry earned degrees in chemistry and biology before completing his Doctor of Pharmacy with honors. His research experience includes pharmaceutical stability testing, transdermal absorption, solid-dose formulation, and the blinded preparation and dispensing of investigational products for clinical studies. He is also a published researcher with extensive experience translating research formulations into reproducible pharmacy production.

Assistant Professor of Chemistry | Medicinal Chemistry & Bioanalytical Consultant
Michael F. Wempe is an Assistant Professor of Chemistry at Georgetown College in Kentucky and a scientific consultant specializing in medicinal chemistry and bioanalysis. His expertise includes drug development, analytical chemistry, ADME, pharmacokinetics, drug metabolism, and preclinical evaluation. Before joining Georgetown College, Dr. Wempe served as an Associate Research Professor and Director of the Medicinal Chemistry Core at the University of Colorado Anschutz Medical Campus. His career also includes pharmaceutical-industry experience with Novartis and Eastman Chemical Company. Dr. Wempe has contributed to more than 120 scientific publications, as well as multiple patents and patent applications, and provides advanced analytical support for pharmaceutical potency, purity, dissolution, stability, and biological-sample testing.
Have a research idea, formulation challenge, or investigational project that needs a practical path forward? Tell us a little about what you are working on and where you could use help.
You do not need to have every detail figured out—we are happy to start with a conversation.Practical guidance. Experienced partners. A realistic next step.